264 related articles for article (PubMed ID: 10738219)
21. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
23. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
24. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
25. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion.
Barrett TL; Greenway HT; Massullo V; Carlson C
Adv Dermatol; 1993; 8():277-304; discussion 305. PubMed ID: 8240916
[No Abstract] [Full Text] [Related]
26. Potential utility of adjunctive histopathologic evaluation of some tumors treated by Mohs micrographic surgery.
Weisberg NK; Becker DS
Dermatol Surg; 2000 Nov; 26(11):1052-6. PubMed ID: 11096394
[TBL] [Abstract][Full Text] [Related]
27. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
Lee DA; Ratner D
Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
[TBL] [Abstract][Full Text] [Related]
28. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
29. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
31. Triage in Mohs micrographic surgery.
Miladi A; Bingham J
J Drugs Dermatol; 2011 Mar; 10(3):257-9. PubMed ID: 21369641
[TBL] [Abstract][Full Text] [Related]
32. Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5-year outcomes.
Adams A; De'Ambrosis B; Panizza B; Belt P; Emmett J; Warren T; Whiteman DC
Australas J Dermatol; 2020 Aug; 61(3):226-230. PubMed ID: 32285436
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of nerves in Mohs micrographic surgery: histologic mimickers of perineural invasion and nervous tissue on frozen section.
Shimizu I; Thomas VD
Dermatol Surg; 2014 May; 40(5):497-504. PubMed ID: 24684417
[TBL] [Abstract][Full Text] [Related]
34. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
35. Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy.
Smith SP; Foley EH; Grande DJ
J Dermatol Surg Oncol; 1990 Nov; 16(11):1012-6. PubMed ID: 2246406
[TBL] [Abstract][Full Text] [Related]
36. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
37. Basal cell carcinoma with intravascular invasion: A case report and review of the literature.
Mazloom S; Rich M; Grider D; Phillips M
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677816
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
39. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
40. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
